Recent studies have shown that the onset and progression of various cancers, including bladder cancer (BCa), breast cancer (BC), cervical cancer (CC), colorectal cancer (CRC), and so on, are associated with NAT10‐catalyzed ac4C modification. Here, NAT10 is linked to urinary bladder carcinoma.